tradingkey.logo

Sol Gel Technologies Ltd

SLGL
View Detailed Chart

30.500USD

+3.932+14.80%
Close 09/19, 16:00ETQuotes delayed by 15 min
84.97MMarket Cap
LossP/E TTM

Sol Gel Technologies Ltd

30.500

+3.932+14.80%
Intraday
1m
30m
1h
D
W
M
D

Today

+14.80%

5 Days

+22.93%

1 Month

+71.93%

6 Months

+423.61%

Year to Date

+227.92%

1 Year

+334.29%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a . Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
209 / 506
Overall Ranking
334 / 4720
Industry
Biotechnology & Medical Research

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
60.000
Target Price
+677.71%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 197.14% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 11.54M.
Fairly Valued
The company’s latest PE is -11.57, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 2.50M shares, decreasing 4.02% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 0.00 shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
Ticker SymbolSLGL
CompanySol Gel Technologies Ltd
CEO
Websitehttp://www.sol-gel.com
KeyAI